|
ATF6B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.104000E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.021010E-03 |
| Normal-vs-Stage2 |
2.615000E-01 |
| Normal-vs-Stage3 |
1.873240E-01 |
| Normal-vs-Stage4 |
2.012800E-01 |
| Stage1-vs-Stage2 |
2.305600E-01 |
| Stage1-vs-Stage3 |
3.150500E-02 |
| Stage1-vs-Stage4 |
1.003620E-01 |
| Stage2-vs-Stage3 |
8.420600E-01 |
| Stage2-vs-Stage4 |
8.953600E-01 |
| Stage3-vs-Stage4 |
9.291600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.552200E-02 |
| Normal-vs-AfricanAmerican |
9.018700E-03 |
| Normal-vs-Asian |
5.227600E-02 |
| Caucasian-vs-AfricanAmerican |
1.325590E-01 |
| Caucasian-vs-Asian |
3.213200E-01 |
| AfricanAmerican-vs-Asian |
8.765400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.062040E-01 |
| Normal-vs-Female |
1.637520E-04 |
| Male-vs-Female |
9.583800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.185600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.019100E-03 |
| Normal-vs-Age(61-80Yrs) |
6.526200E-02 |
| Normal-vs-Age(81-100Yrs) |
7.848400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.980000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.140000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.512200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.369400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.632180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.136200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.12130005280875E-09 |
| Normal-vs-Grade 2 |
7.554100E-04 |
| Normal-vs-Grade 3 |
1.893250E-01 |
| Normal-vs-Grade 4 |
5.723400E-01 |
| Grade 1-vs-Grade 2 |
4.18020000000352E-05 |
| Grade 1-vs-Grade 3 |
2.82340000268277E-08 |
| Grade 1-vs-Grade 4 |
2.82880000535002E-08 |
| Grade 2-vs-Grade 3 |
8.762900E-03 |
| Grade 2-vs-Grade 4 |
1.309500E-02 |
| Grade 3-vs-Grade 4 |
5.038400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.139510E-03 |
| Normal-vs-ccB subtype |
2.243000E-01 |
| ccA subtype-vs-ccB subtype |
1.775540E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.056800E-03 |
| Normal-vs-N1 |
9.123600E-01 |
| N0-vs-N1 |
2.848400E-01 |
|
|
